Literature DB >> 9880544

Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex.

A Vassilev1, Z Ozer, C Navara, S Mahajan, F M Uckun.   

Abstract

Bruton's tyrosine kinase (BTK) is a member of the Src-related Tec family of protein tyrosine kinases. Mutations in the btk gene have been linked to severe developmental blocks in human B-cell ontogeny leading to X-linked agammaglobulinemia. Here, we provide unique biochemical and genetic evidence that BTK is an inhibitor of the Fas/APO-1 death-inducing signaling complex in B-lineage lymphoid cells. The Src homology 2, pleckstrin homology (PH), and kinase domains of BTK are all individually important and apparently indispensable, but not sufficient, for its function as a negative regulator of Fas-mediated apoptosis. BTK associates with Fas via its kinase and PH domains and prevents the FAS-FADD interaction, which is essential for the recruitment and activation of FLICE by Fas during the apoptotic signal. Fas-resistant DT-40 lymphoma B-cells rendered BTK-deficient through targeted disruption of the btk gene by homologous recombination knockout underwent apoptosis after Fas ligation, but wild-type DT-40 cells or BTK-deficient DT-40 cells reconstituted with wild-type human btk gene did not. Introduction of an Src homology 2 domain, a PH domain, or a kinase domain mutant human btk gene into BTK-deficient cells did not restore the resistance to Fas-mediated apoptosis. Introduction of wild-type BTK protein by electroporation rendered BTK-deficient DT-40 cells resistant to the apoptotic effects of Fas ligation. BTK-deficient RAMOS-1 human Burkitt's leukemia cells underwent apoptosis after Fas ligation, whereas BTK-positive NALM-6-UM1 human B-cell precursor leukemia cells expressing similar levels of Fas did not. Treatment of the anti-Fas-resistant NALM-6-UM1 cells with the leflunomide metabolite analog alpha-cyano-beta-methyl-beta-hydroxy-N-(2, 5-dibromophenyl)propenamide, a potent inhibitor of BTK, abrogated the BTK-Fas association without affecting the expression levels of BTK or Fas and rendered them sensitive to Fas-mediated apoptosis. The ability of BTK to inhibit the pro-apoptotic effects of Fas ligation prompts the hypothesis that apoptosis of developing B-cell precursors during normal B-cell ontogeny may be reciprocally regulated by Fas and BTK.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9880544     DOI: 10.1074/jbc.274.3.1646

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia.

Authors:  Kumudha Balakrishnan; Varsha Gandhi
Journal:  Expert Opin Investig Drugs       Date:  2012-03-09       Impact factor: 6.206

2.  Coexpression network based on natural variation in human gene expression reveals gene interactions and functions.

Authors:  Renuka R Nayak; Michael Kearns; Richard S Spielman; Vivian G Cheung
Journal:  Genome Res       Date:  2009-10-01       Impact factor: 9.043

3.  The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils.

Authors:  Fumiko Honda; Hirotsugu Kano; Hirokazu Kanegane; Shigeaki Nonoyama; Eun-Sung Kim; Sang-Kyou Lee; Masatoshi Takagi; Shuki Mizutani; Tomohiro Morio
Journal:  Nat Immunol       Date:  2012-02-26       Impact factor: 25.606

4.  Hypoxia and low glucose differentially augments TRAIL-induced apoptotic death.

Authors:  Yong J Lee; Mi-Sun Moon; Seok J Kwon; Juong G Rhee
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

5.  Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis.

Authors:  Shi Pan; Ping An; Rong Zhang; Xiangrong He; Guoyong Yin; Wang Min
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

6.  Optimized Near-IR Fluorescent Agents for in Vivo Imaging of Btk Expression.

Authors:  Eunha Kim; Katherine S Yang; Rainer H Kohler; John M Dubach; Hannes Mikula; Ralph Weissleder
Journal:  Bioconjug Chem       Date:  2015-06-09       Impact factor: 4.774

7.  A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria.

Authors:  Carolyn Wiltshire; Masato Matsushita; Satoshi Tsukada; David A F Gillespie; Gerhard H W May
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

8.  Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib.

Authors:  Melissa G Ooi; Patrick J Hayden; Vassiliki Kotoula; Douglas W McMillin; Elpida Charalambous; Emily Daskalaki; Noopur S Raje; Nikhil C Munshi; Dharminder Chauhan; Teru Hideshima; Leutz Buon; Martin Clynes; Peter O'Gorman; Paul G Richardson; Constantine S Mitsiades; Kenneth C Anderson; Nicholas Mitsiades
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

9.  A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis.

Authors:  Cheryl Eifert; Xianhui Wang; Leila Kokabee; Antonis Kourtidis; Ritu Jain; Michael J Gerdes; Douglas S Conklin
Journal:  Genes Chromosomes Cancer       Date:  2013-08-03       Impact factor: 5.006

10.  Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45.

Authors:  Mitsuhiko Osaki; Satoru Kase; Keiko Adachi; Ami Takeda; Kiyoshi Hashimoto; Hisao Ito
Journal:  J Cancer Res Clin Oncol       Date:  2003-11-07       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.